Innovent Biologics' Mazdutide Application Accepted by China's NMPA: A New Hope for Obesity Treatment Innovent Biologics' 9 mg dosed Mazdutide has been accepted for review by China's NMPA. This novel treatment promises effective weight loss solutions for the obese population in China.

Innovent Biologics' Mazdutide Application Accepted by China's NMPA: A New Hope for Obesity Treatment #China #Suzhou #Innovent_Biologics #Mazdutide #China_NMPA